EGF antibody (AA 660-709)
Quick Overview for EGF antibody (AA 660-709) (ABIN2885862)
Target
See all EGF AntibodiesReactivity
Host
Clonality
Conjugate
Application
-
-
Binding Specificity
- AA 660-709
-
Specificity
- EGF antibody detects endogenous levels of EGF.
-
Purification
- Immunoaffinity purified
-
Immunogen
-
Synthetic peptide derived from human EGF (aa660-709).
Type of Immunogen: Synthetic peptide -
Isotype
- IgG
-
-
-
-
Application Notes
- Approved: IHC, Peptide-ELISA (1:10000), WB (1:500 - 1:1000)
-
Comment
-
Target Species of Antibody: Human
-
Restrictions
- For Research Use only
-
-
-
Format
- Liquid
-
Concentration
- Lot specific
-
Buffer
- PBS, pH 7.4, 150 mM sodium chloride, 0.02 % sodium azide, 50 % glycerol.
-
Preservative
- Sodium azide
-
Precaution of Use
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Storage
- -20 °C
-
Storage Comment
- Store at -20°C.
-
-
- EGF (Epidermal Growth Factor (EGF))
-
Alternative Name
- EGF
-
Background
-
Name/Gene ID: EGF
Synonyms: EGF, Beta-urogastrone, HOMG4, URG, Epidermal growth factor, Pro-epidermal growth factor -
Gene ID
- 1950
-
Pathways
- NF-kappaB Signaling, RTK Signaling, Fc-epsilon Receptor Signaling Pathway, EGFR Signaling Pathway, Neurotrophin Signaling Pathway, Regulation of Carbohydrate Metabolic Process, Hepatitis C, Protein targeting to Nucleus, Interaction of EGFR with phospholipase C-gamma, Thromboxane A2 Receptor Signaling, EGFR Downregulation
Target
-